| scholarly article | Q13442814 |
| P2093 | author name string | Laurent R | |
| Panayi GS | |||
| Hanlon SM | |||
| P2860 | cites work | Characterization of serum inhibitors of neutrophil chemotaxis associated with anergy | Q47864822 |
| Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. | Q53021508 | ||
| Defective leukotaxis in patients with lepromatous leprosy | Q67484331 | ||
| Routine assay for the detection of immune complexes of known immunoglobulin class using solid phase C1q | Q67755674 | ||
| A serum inhibitor of leukotaxis in a child with recurrent infections | Q69174246 | ||
| The assessment of rheumatoid arthritis. A study based on measurements of the serum acute-phase reactants | Q69204369 | ||
| A simplified method for the measurement of chemotaxis of polymorphonuclear leukocytes from human blood | Q71780818 | ||
| Neutrophil chemotaxis in systemic lupus erythematosus | Q33568907 | ||
| Defective responsiveness to ascorbic acid of neutrophil random and chemotactic migration in Felty's syndrome and systemic lupus erythematosus | Q33569830 | ||
| Serum chemotactic inhibitory activity: heat activation of chemotactic inhibition | Q34389731 | ||
| Chemotactic factor inactivator in normal human serum | Q34504246 | ||
| Characterization of the protease activity in the chemotactic factor inactivator | Q35902491 | ||
| The chemosuppression of chemotaxis | Q36334629 | ||
| Two distinct chemotactic factor inactivators in human serum | Q39314460 | ||
| Factors relating to circulating immune complexes in rheumatoid arthirits | Q41366570 | ||
| Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor | Q42836658 | ||
| Defective chemotaxis associated with a serum inhibitor in cirrhotic patients | Q43433215 | ||
| A raft technique for chemotaxis: a versatile method suitable for clinical studies | Q43861281 | ||
| Hemolytic assay of the ninth complement complement component: elevation and depletion in rheumatic diseases | Q43914816 | ||
| Leukotactic dystunction in sarcoidosis | Q44257076 | ||
| Defective regulation of inflammatory mediators in Hodgkin's disease. Supernormal levels of chemotactic-factor inactivator | Q44580304 | ||
| Inhibitors of leukocyte chemotaxis in alcoholic liver disease | Q44639650 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| chemotaxis | Q658145 | ||
| P304 | page(s) | 68-74 | |
| P577 | publication date | 1980-02-01 | |
| P1433 | published in | Annals of the Rheumatic Diseases | Q4767876 |
| P1476 | title | Defective polymorphonuclear leucocyte chemotaxis in rheumatoid arthritis associated with a serum inhibitor | |
| P478 | volume | 39 |
| Q71941369 | Auranofin and its combination with LTB4 influences ATP level and migration of human polymorphonuclear cells in vitro |
| Q33562876 | Chemotaxis and chemiluminescence responses of synovial fluid polymorphonuclear leucocytes during acute reactive arthritis |
| Q43495389 | Effects of methotrexate, sulphasalazine and aurothiomalate on polymorphonuclear leucocytes in rheumatoid arthritis |
| Q40134319 | Host defenses against infection: importance of phagocytic mechanisms from the study of genetic disorders of leukocyte function |
| Q33555218 | Impaired polymorphonuclear leucocyte chemotaxis in rheumatoid arthritis |
| Q33553041 | Polymorphonuclear cell function in rheumatoid arthritis and in Felty's syndrome |
| Q92078915 | RA-map: building a state-of-the-art interactive knowledge base for rheumatoid arthritis |
| Q33564417 | Staphylococcal infections in childhood dermatomyositis--association with the development of calcinosis, raised IgE concentrations and granulocyte chemotactic defect |
| Q69486833 | Studies of polymorphonuclear migration into psoriatic skin using a new in vivo method |
| Q33556024 | Subnormal sensitivity of neutrophils to complement split product C5a in rheumatoid arthritis: relation to complement catabolism and disease extent |
Search more.